Tushar Bhikhubhai Patel is 10% Owner at Amneal Pharmaceuticals, Inc. (AMRX). They have made 1 open-market trade across 1 company since 2025, most recently 2026-08-10.
CIK 0001745375
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AMRX | 61,341,678 | $1.2B |
Shares reported on the most recent Form 4, priced at the 2026-08-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AMRX | SELL | 2025-03-14 | 2025-03-17 | $8.35 | $41.8M | -3.7% | -16.3% | -5.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.